AU2789089A - Phosphoryled derivatives of cardiodilatine/anf peptides - Google Patents

Phosphoryled derivatives of cardiodilatine/anf peptides

Info

Publication number
AU2789089A
AU2789089A AU27890/89A AU2789089A AU2789089A AU 2789089 A AU2789089 A AU 2789089A AU 27890/89 A AU27890/89 A AU 27890/89A AU 2789089 A AU2789089 A AU 2789089A AU 2789089 A AU2789089 A AU 2789089A
Authority
AU
Australia
Prior art keywords
derivatives
cardiodilatine
phosphoryled
anf
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27890/89A
Inventor
Wolf-Georg Forssmann
Michael Gagelmann
Dieter Hock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bissendorf Peptide GmbH
Original Assignee
Bissendorf Peptide GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bissendorf Peptide GmbH filed Critical Bissendorf Peptide GmbH
Publication of AU2789089A publication Critical patent/AU2789089A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Derivatives of precursor peptide of the cardiodilatine/atrial natriuretic factor (CDD-ANF) or fragments thereof which contain the amino acid sequence of alpha-hANaP. The derivatives are compounds having the formula (I). Also described is a process for qualitative and quantitative determination of peptides which contain the alpha-hANaP sequence and the use of the compounds of formula (I) as drugs.
AU27890/89A 1987-11-07 1988-11-04 Phosphoryled derivatives of cardiodilatine/anf peptides Abandoned AU2789089A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3737917 1987-11-07
DE19873737917 DE3737917A1 (en) 1987-11-07 1987-11-07 PHOSPHORYLATED DERIVATIVES OF CARDIODILATIN / ANF PEPTIDES

Publications (1)

Publication Number Publication Date
AU2789089A true AU2789089A (en) 1989-06-01

Family

ID=6340060

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27890/89A Abandoned AU2789089A (en) 1987-11-07 1988-11-04 Phosphoryled derivatives of cardiodilatine/anf peptides

Country Status (6)

Country Link
EP (1) EP0386076B1 (en)
JP (1) JP2727098B2 (en)
AT (1) ATE85346T1 (en)
AU (1) AU2789089A (en)
DE (2) DE3737917A1 (en)
WO (1) WO1989004324A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2188143A1 (en) * 1992-12-09 1995-11-02 Wolf-Georg Forssmann Use of brain natriuretic peptides (bnp), phosphorylated urodilatine, phosphorylated cdd/anp and combinations thereof
DE19850964C2 (en) * 1998-09-28 2003-03-27 Mueller Weingarten Maschf Device for the transport of workpieces
AU2009308462B2 (en) 2008-10-21 2015-06-11 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Animal model for evaluating vasomotor response in vivo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508712A (en) * 1984-01-10 1985-04-02 Washington University Atrial peptide
DE3443257A1 (en) * 1984-11-28 1986-05-28 Bissendorf Peptide GmbH, 3002 Wedemark MEDIUM CONTAINING FULLY SYNTHETIC ALPHA-HUMAN ATRIAL NATURAL PEPTIDE (ALPHA-HANAP)

Also Published As

Publication number Publication date
WO1989004324A1 (en) 1989-05-18
EP0386076B1 (en) 1993-02-03
ATE85346T1 (en) 1993-02-15
JPH03500776A (en) 1991-02-21
DE3737917A1 (en) 1989-05-18
JP2727098B2 (en) 1998-03-11
DE3878254D1 (en) 1993-03-18
EP0386076A1 (en) 1990-09-12

Similar Documents

Publication Publication Date Title
AU630951B2 (en) Enzymatic removal of a protein amino-terminal sequence
AU578057B2 (en) Alpha-human atrial natriuretic polypeptide
CA2207078A1 (en) Insulin derivatives with increased zinc binding
NO850709L (en) PROCEDURE FOR THE PREPARATION OF ATRIAL PEPTIDES.
CA2004991A1 (en) Deletion analogues of magainin peptides
Buko et al. Peptide studies using a fast atom bombardment high field mass spectrometer and data system. 4. Disulfide‐containing peptides
AU1348188A (en) New cardiodilatin fragment, process for preparing same and use thereof
AU4971385A (en) A process for the cleavage of peptides and proteins at the methionyl bond
KR840009069A (en) Method for producing psychotropic peptides
EP0206090A3 (en) Peptide renin inhibitors
AU600907B2 (en) Peptide amino-alcohol derivatives containing a tetrasubstituted carbon atom, inhibiting renin and acid proteases, process for obtention and therapeutical use
ES2015366A6 (en) Elastase inhibiting polypeptides and process for their preparation by genetic recombination.
IE902388L (en) Vasoactive intestinal peptide analogs.
AU613228B2 (en) A new antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical
AU2789089A (en) Phosphoryled derivatives of cardiodilatine/anf peptides
AU585167B2 (en) Novel substrate peptides
EP0297068A3 (en) Mammal intestine hormone precursor
AU3524993A (en) Method of peptide synthesis and new synthesis intermediates
ATE70454T1 (en) PRODUCT CONTAINING VINCRISTIN.
ATE224403T1 (en) USE OF CASEIN FRAGMENTS AS GROWTH PROMOTERS
AU586352B2 (en) Process for concentration of an aqueous solution of amino acid
DE3665462D1 (en) Pharmacologically active peptides
AU6478294A (en) Process for the preparation of an alpha-amino acid amide
AU4329489A (en) Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer
AU6478194A (en) Ureins derived from alpha,omega-diamino acids and process for their preparation